课题基金 / 基金详情

Ventricular Remodeling in the Adapted Heart

Ventricular Remodeling in the Adapted Heart
适应心脏的心室重塑
批准号:
7261984
负责人:
NILANJANA MAULIK
金额:
$34.37万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-01 至 2009-03-16
关键词:
1-Phosphatidylinositol 3-KinaseAddressAdultAngiogenic FactorAngiopoietin-2AnimalsAntibodiesApoptosisApoptoticAreaArteriesBAD geneBad proteinBindingBiological AssayBiological ProcessBlood capillariesBlood flowBromodeoxyuridineCandidate Disease GeneCardiacCardiac MyocytesCell DeathCell ProliferationCell SurvivalCessation of lifeChronicCollaborationsCollagenCoronaryCoronary arteryCoronary heart diseaseCyclic AMP-Dependent Protein KinasesDevelopmentDimerizationDisruptionDoctor of PhilosophyDrug or chemical Tissue DistributionEMSAEndothelial CellsEngineeringEnzyme-Linked Immunosorbent AssayEvaluationExperimental ModelsExtracellular MatrixFaceFunctional disorderGeneticHeartHeart failureHumanHypertrophyHypoxemiaHypoxiaImmunohistochemistryIn Situ HybridizationIn Situ Nick-End LabelingIn VitroInfarctionInhibition of ApoptosisInterventionIschemic PreconditioningIsoenzymesKnockout MiceLY294002LabelLaboratoriesLeftMAP Kinase GeneMeasuresMediatingMitochondriaMitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesMitogensModalityModelingMolecularMolecular ProfilingMonitorMusMuscle CellsMyocardialMyocardial InfarctionMyocardial IschemiaMyocardiumNF-kappa BNecrosisNitric OxidePDPK1 genePECAM1 genePathway interactionsPatientsPatternPerformancePersonal SatisfactionPhosphatidylinositide 3-Kinase InhibitorPhospholipidsPhosphorylationPhosphotransferasesPlayProcessProductionProtein IsoformsProtein Kinase CProteinsProto-Oncogene Proteins c-aktProtocols documentationRattusReadinessReceptor Protein-Tyrosine KinasesRecoveryRegulationReportingResearchRetroviral VectorRiskRoleSignal PathwaySignal TransductionSignal Transduction PathwaySiteSmooth Muscle Actin Staining MethodStaining methodStainsStimulusStressSystemTP53 geneTestingTherapeuticTissuesTranscriptional RegulationUp-RegulationVascular Endothelial CellVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth FactorsVascular EndotheliumVascular blood supplyVascular remodelingVentricularVentricular FunctionVentricular RemodelingWeekWestern Blottingangiogenesisartery occlusioncapillarycaspase-9citrate carrierclinically relevantdensityforkhead proteingene therapyin vivoinhibitor/antagonistinsightinterestneutralizing antibodynew growthnovel therapeuticspreconditioningpro-apoptotic proteinprotein expressionreceptorresearch studyresponsesizesurvivintranscription factorwortmannin

项目摘要

项目成果

NILANJANA MAULIK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Following myocardial infarction (MI), there is a progressive myocardial remodeling characterized by left ventricular (LV) dilation, contractile dysfunction, myocyte hypertrophy and increased matrix protein formation. The proposed project will examine the molecular mechanism(s) of hypoxic preconditioning (HP)- mediated myocardial remodeling in the infarcted heart by studying cardioprotective parameters at the transcriptional and protein level. We have established the optimal hypoxic preconditioning stimulus in rat MI model (10%O2/90%NS) to initiate capillary/arteriolar formation, increased blood flow and ventricular function in the myocardium. To establish the role of such HP in potentiating the signal transduction process for ventricular remodeling we will examine (i) the expression of VEGF and its tyrosine kinase receptors VEGFR1 (Flt-1) and VEGFR2 (FIk-1), expression and activity of protein kinase C, MAP Kinases-Aim I (ii) the expression and activity of iNOS/eNOS will be determined along with the transcriptional regulation of these factors by NFkB, Stat1-Aim 2 (iii) the extent of endothelial cell (EC) survival and the extent of necrosis/apoptosis, anti-apoptotic proteins Bcl-2, survivin expression, PI-3-Kinase activity, and the extent of AKT/BAD phosphorylation -Aim 3. Our rat MI model subjected to HP before LAD occlusion has significant advantage to study the molecular mechanism of myocardial remodeling over several months. An obligatory role of FIk-1, iNOS and eNOS in VEGF mediated signaling in myocardial angiogenesis/remodeling will be established by the use of Flk1, iNOS-/- and eNOS-/- knockout mice. The endothelial cell proliferation will be studied by BrdU incorporation assay, cardiomyocyte and endothelial cell apoptosis will be studied by double antibody staining, capillary and arteriolar density will be determined by labeling endothelial and smoothe muscle cells using anti-rat CD31 and anti-smooth muscle actin respectively. The results of this study will establish whether protein kinase-C, MAP kinases, eNOS/iNOS/NO are involved in VEGF and/or receptors (FIk-1/FIt-1) mediated myocardial regulation of HP induced remodeling in rat MI model. The results will provide new information required for new therapeutic strategies to protect the heart in patients with cardiac stress or coronary heart disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Angiogenic Regulators in Ischemic Disorders
Angiogenic Regulators in Ischemic Disorders
Mechanism of Myocardial Angiogenesis in Transgenic/Knockout Animals
Mechanism of Myocardial Angiogenesis in Transgenic/Knockout Animals
海外基金